SCHEMBL485228

SCHEMBL485228

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(CCCc5cccc(F)c5)CC4)C3)cc21)c1cc(Cl)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 10/20 0.40
CYP3A4 P08684 7/20 0.40
CYP1A2 P05177 4/20 0.40
HPGD P15428 3/20 0.40
HTR1A P08908 3/20 0.40
DRD2 P14416 3/20 0.40
HTR2A P28223 3/20 0.40
KCNH2 Q12809 3/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 1/20 0.39
RECQL P46063 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
USP2 O75604 4/20 0.37
CYP2C9 P11712 3/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2C19 P33261 2/20 0.37
ACKR3 P25106 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484351 0.92 DRD2 (0.41) HTR1ADRD2HTR2AKCNH2MEN1
SCHEMBL485017 0.91 CYP2D6 (0.40) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL485023 0.89 CYP2D6 (0.42) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL484935 0.88 CYP3A4 (0.40) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL484786 0.87 CYP2D6 (0.39) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL484680 0.86 CYP2D6 (0.44) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL2815768 0.85 KCNH2 (0.46) CYP2D6HTR1ADRD2HTR2AKCNH2
SCHEMBL484772 0.84 DRD2 (0.42) CYP2D6CYP3A4CYP1A2HPGDHTR1A
SCHEMBL2816489 0.84 CYP2D6 (0.37) CYP2D6CYP3A4CYP1A2HPGDKCNH2
SCHEMBL2819125 0.84 ACKR3 (0.40) CYP2D6CYP3A4CYP1A2HPGDHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP1A2 3400/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP1A2 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.